Treatment of Ocular Myasthenia
- 1 May 2000
- journal article
- controversies in-neurology
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 57 (5), 752-753
- https://doi.org/10.1001/archneur.57.5.752
Abstract
MYASTHENIA gravis (MG) preferentially involves the ocular muscles.1 Ocular myasthenia manifests as weakness of the levator palpebrae superioris leading to ptosis, or the extraocular muscles producing diplopia. The precise reasons for this predilection are poorly understood.2,3 As with all therapies for MG, there are few well-controlled studies of treatments of ocular myasthenia.4 Immunosuppressive therapies, in particular the corticosteroid prednisone, are the mainstay of treatment for generalized MG that compromises an individual's daily activities. Prednisone is also commonly used for ocular myasthenia. However, 4 factors should be considered prior to the use of steroids for patients with MG isolated to the ocular muscles: (1) Could the patient's symptoms improve with safer forms of therapy? (2) Will steroid treatment lead to resolution of symptoms? (3) Does the severity of the symptoms warrant the risk of steroid adverse effects? (4) Do steroids reduce the chance of generalization? We consider each of these questions and reach the conclusion that only the occasional case of ocular myasthenia should be treated with steroids.Keywords
This publication has 9 references indexed in Scilit:
- Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced OsteoporosisNew England Journal of Medicine, 1997
- Ocular myasthenia gravis: response to long-term immunosuppressive treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Beneficial Effects of Corticosteroids on Ocular Myasthenia GravisArchives of Neurology, 1996
- Factors influencing outcome of prednisone dose reduction in myasthenia gravisNeurology, 1991
- The natural course of myasthenia gravis.BMJ, 1990
- Ocular myasthenia: diagnostic and therapeutic problemsActa Neurologica Scandinavica, 1988
- The Course of Myasthenia Gravis and Therapies Affecting OutcomeaAnnals of the New York Academy of Sciences, 1987
- Prognosis of ocular myastheniaAnnals of Neurology, 1983
- COURSE AND MANAGEMENT OF MYASTHENIA GRAVISPublished by American Medical Association (AMA) ,1953